Pre-ischemic Treatment with Ampicillin Reduces Neuronal Damage in the Mouse Hippocampus and Neostriatum after Transient Forebrain Ischemia

  • Lee, Kyung-Eon (Department of Pharmacology, Cell Death Disease Research Center, College of Medicine, The Catholic University of Korea) ;
  • Kim, Seul-Ki (Department of Pharmacology, Cell Death Disease Research Center, College of Medicine, The Catholic University of Korea) ;
  • Cho, Kyung-Ok (Department of Pharmacology, Cell Death Disease Research Center, College of Medicine, The Catholic University of Korea) ;
  • Kim, Seong-Yun (Department of Pharmacology, Cell Death Disease Research Center, College of Medicine, The Catholic University of Korea)
  • Published : 2008.12.31


Ampicillin, a $\beta$-lactam antibiotic, has been reported to induce astrocytic glutamate transporter-l which plays a crucial role in protecting neurons against glutamate excitotoxicity. We investigated the effect of ampicillin on neuronal damage in the mouse hippocampus and neostriatum following transient global forebrain ischemia. Male C57BL/6 mice were anesthetized with halothane and subjected to bilateral occlusion of the common carotid artery for 40 min. Ampicillin was administered post-ischemically (for 3 days) and/or pre-ischemically (for $3{\sim}5$ days until one day before the onset of ischemia). Pre- and post-ischemic treatment with ampicillin (50 mg/kg/day or 200 mg/kg/day) prevented ischemic neuronal death in the medial CAI area of the hippocampus as well as the neostriatum in a dose-dependent manner. In addition, ischemic neuronal damage was reduced by pre-ischemic treatment with ampicillin (200 mg/kg/day). In summary, our results suggest that ampicillin plays a functional role as a chemical preconditioning agent that protects hippocampal neurons from ischemic insult.


  1. Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32: 1-14, 2000<1::AID-GLIA10>3.0.CO;2-W
  2. Benveniste H. The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovasc Brain Metab Rev 3: 213-245, 1991
  3. Cho KO, Kim SK, Cho YJ, Sung KW, Kim SY. A simple method for predicting hippocampal neurodegeneration in a mouse model of transient global forebrain ischemia. Korean J Physiol Pharmacol 10: 167-172, 2006
  4. Chu K, Lee ST, Sinn DI, Ko SY, Kim EH, Kim JM, Kim SJ, Park DK, Jung KH, Song EC, Lee SK, Kim M, Roh JK. Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation. Stroke 38: 177-182, 2007
  5. English AR, Girard D, Haskell SL. Pharmacokinetics of sultamicillin in mice, rats, and dogs. Antimicrob Agents Chemother 25: 599-602, 1984
  6. Huber R, Kasischke K, Ludolph AC, Riepe MW. Increase of cellular hypoxic tolerance by erythromycin and other antibiotics. Neuroreport 10: 1543-1546, 1999
  7. Ji HF, Shen L, Zhang HY. Beta-lactam antibiotics are multipotent agents to combat neurological diseases. Biochem Biophys Res Commun 333: 661-663, 2005
  8. Kanra G. Experience with ampicillin/sulbactam in severe infections. J Int Med Res 30 (1 Suppl): 20A-30A, 2002
  9. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239: 57-69, 1982
  10. Lee SG, Su ZZ, Emdad L, Gupta P, Sarkar D, Borjabad A, Volsky DJ, Fisher PB. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J Biol Chem 283: 13116-13123, 2008
  11. Lipski J, Wan CK, Bai JZ, Pi R, Li D, Donnelly D. Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience 146: 617-629, 2007
  12. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 79: 1431-1568, 1999
  13. Lo EH, Moskowitz MA, Jacobs TP. Exciting, radical, suicidal: how brain cells die after stroke. Stroke 36: 189-192, 2005
  14. Lutsar I, McCracken GH, Friedland IR. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis 27: 1117-1128, 1998
  15. Mordenti J, Chappell W. The use of interspecies scaling in toxicokinetics. In: Yacobi A, Kelly J, Batra V eds, Toxicokinetics and new drug development. Pergamon Press, New York, p 42-96, 1989
  16. Murakami K, Kondo T, Kawase M, Chan PH. The development of a new mouse model of global ischemia: focus on the relationships between ischemia duration, anesthesia, cerebral vasculature, and neuronal injury following global ischemia in mice. Brain Res 780: 304-310, 1998
  17. Ouyang YB, Voloboueva LA, Xu LJ, Giffard RG. Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. J Neurosci 27: 4253-4260, 2007
  18. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 2nd ed. Academic Press, London, 2001
  19. Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med 336: 708-716, 1997
  20. Rao VL, Dogan A, Todd KG, Bowen KK, Kim BT, Rothstein JD, Dempsey RJ. Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain. J Neurosci 21: 1876-1883, 2001
  21. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433: 73-77, 2005
  22. Swanson RA, Ying W, Kauppinen TM. Astrocyte influences on ischemic neuronal death. Curr Mol Med 4: 193-205, 2004
  23. Watase K, Hashimoto K, Kano M, Yamada K, Watanabe M, Inoue Y, Okuyama S, Sakagawa T, Ogawa S, Kawashima N, Hori S, Takimoto M, Wada K, Tanaka K. Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice. Eur J Neurosci 10: 976-988, 1998
  24. Zhou J, Sutherland ML. Glutamate transporter cluster formation in astrocytic processes regulates glutamate uptake activity. J Neurosci 24: 6301-6306, 2004